An innovative project of Mount Sinai Medical Center in New York City, HepCure is improving provider knowledge & patient engagement for chronic disease management in persons infected with the Hepatitis C Virus (HCV). The toolkit is designed to address barriers for the effective care and treatment of HCV by providing web-based and smartphone enabled resources, navigation, consultation, and support for both patients and providers. The HepCure toolkit draws upon the experience of expert providers within the Mount Sinai Network, with support and development by Sinai AppLab, Mount Sinai Medical Center. HepCure was developed by the Mount Sinai Division of Liver Diseases, Division of General Internal Medicine, and the Informatics for Research, Outcomes, and Quality initiative in the Division of Gastroenterology.
HepCure is a secure, cloud-based provider portal meant to virtually navigate providers through hepatitis C virus (HCV) care. The HepCure dashboard integrates tools to more effectively manage HCV infected patients. A flexible, scalable platform, the HepCure Dashboard provides a seamless flow of information within a digital healthcare infrastructure. HepCure enables easy access to HCV resources and best-practices for optimal management of HCV patients with the opportunity to engage patients on treatment, while improving overall health outcomes. The platform serves as an organizational tool, with built-in workflow efficiencies that optimize treatment decisions, reduce redundancies, as well as promote provider training and development.
Through the use of the dashboard and patient app, providers can:
We at HepCure are always looking for ways to improve. That’s why we’re constantly working on new features and meeting new challenges! Here are just a few of the features we plan to explore:
The patient app is a free resource for patients with hepatitis C, which allows them to track medication adherence, symptoms, and gain access to resources. It is available to download for free on iOS (App Store) and Android (Google Play) operating systems. While the app can be used by patients independently from the dashboard, it can also be linked with the provider dashboard. Providers can push lab data to patients and track treatment adherence and symptom data input by patients in real time.
The HepCure Tele-Education Webinar Series features many diverse and salient topics in hepatitis C. Each week, the webinar series showcases different speakers who are prominent members of the hepatitis C community. Our webinars are attended by a wide audience, and include providers, patient navigators, and other health workers from around the globe. Our collaboration with the New York State Clinical Education Initiative (CEI) and Empire Liver Foundation (ELF) allows us to provide continuing education credits (CME/CNE) through attendance to our webinars on the first and last Tuesday of every month.
All webinars are held on Tuesdays from 4:30 - 5:30pm EST
Please join us on Tuesday, September 26th at 4:30 PM EST for a presentation by Dr. Dost Sarpel of the Icahn School of Medicine at Mount Sinai. Dr. Sarpel will present:
“Hepatitis C and HIV Co-Infection”
Dr. Dost Sarpel is an Assistant Professor of Medicine in Infectious Disease at the Icahn School of Medicine at Mount Sinai. He completed medical school at University at Buffalo School of Medicine and Biomedical Sciences, followed by a residency in Internal Medicine at The George Washington University Hospital. He then completed his Infectious Disease fellowship at The George Washington University Hospital in 2012. After working in a private practice Infectious Disease group in the East Bay outside of San Francisco for three years, Dr. Sarpel returned to academics and completed a Viral Hepatology Fellowship under the mentorship of Dr. Douglas Dieterich at Icahn School of Medicine at Mount Sinai, Institute of Liver Medicine. Dr. Sarpel’s main research interests involve hepatitis C patients who have failed DAA therapy, improving hepatocellular carcinoma screening in chronic hepatitis B and C infected patients, and treatment and epidemiology of HCV/HIV and HBV/HIV co-infected patients.
*Free Pre-Registration Required
On Tuesday, September 12th, Dr. Seun Falade-Nwulia of Johns Hopkins Medical Center presented on: “Overcoming barriers to hepatitis C elimination: Our Baltimore experience”
Currently an assistant professor at the Johns Hopkins University School of Medicine, Dr. Seun Falade-Nwulia’s clinical pursuits are focused on care of HIV and HCV infected patients and educating clinicians and public health practitioners about STDs, HIV, and hepatitis. She served as Medical Director of the Baltimore City Health Department Sexually Transmitted Diseases Clinic based HIV care programs until 2015 and also developed and implemented the Baltimore City Health Department HCV testing, linkage to care and treatment programs, establishing the Baltimore City Health Department as a national leader in health department population HCV control programs.
Her research has focused on understanding the distribution and impact of highly active antiretroviral therapy on hepatitis B and C outcomes, and on improving HIV and HCV testing and access to care in medically underserved communities. A particular focus of her research is understanding the transmission of and care uptake for HCV using social network and molecular (such as phylogenic) tools; as a bridge to development of sustainable interventions to increase HCV cure rates, prevent HCV transmission and reinfection and thus control HCV at the population level.
These learning modules are intended for clinicians of all backgrounds who may encounter or treat patients with hepatitis C and would like to establish core competencies in screening & diagnosis, evaluation and management of the disease. Content includes screening and linkage to care, initial evaluation, diagnosis and recognition of clinical manifestations. These modules were originally presented as a component of the HepCure Tele-Education Webinar Series.
These learning modules are intended for clinicians who have experience treating patients with hepatitis C and would like to further their knowledge. These modules were originally presented as a component of the HepCure Tele-Education Webinar Series.
Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment
THe Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment (PREP-C) is a free interactive online tool that enables you to provide a thorough assessment of a patient’s psychosocial readiness to begin Hepatitis C treatment, and make a treatment plan to improve treatment readiness.
This free online tool can be used by any type of professional involved in preparing a patient for Hepatitis C Treatment including medical providers, nurses, mental health, substance use, social work, pharmacy, case management, treatment adherence and health education specialists.